KHT-16045-73230 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-19
Dose 1 — Pfizer-BioNTech
2021-01-13
Dose 2 — Pfizer-BioNTech
2021-01-14
Registered in v-safe
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fever · Headache

Adult check-in
2021-01-16
Survey response — days 1–6 daily, dose 2
MedDRA: Type 1 diabetes mellitus — Feeling: Good

Free text: I have type 1 diabetes (diagnosed 05/1998)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-19	Pfizer-BioNTech
2	2021-01-13	Pfizer-BioNTech

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-16

Systemic reaction (other): I have type 1 diabetes (diagnosed 05/1998)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Type 1 diabetes mellitus	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release